Inpharma Weekly

, Volume 1432, Issue 1, pp 14–14 | Cite as

Temozolomide + irinotecan active in recurrent malignant glioma

Clinical study
  • 6 Downloads

Keywords

Thrombocytopenia Partial Response Recurrent Tumour Disease Stabilisation Irinotecan 

Copyright information

© Adis International Ltd 2004

Personalised recommendations